EUCTR2013-000098-65-NO进行中（未招募）不适用
Treatment of Axial Spondyloarthritis with reduced doses of NSAIDs: Application of pharmacotherapeutic conditioning in clinical practice.
niversity of Tromsø0 个研究点开始时间: 2013年6月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Pasients must have been diagnosed with radiographic Axial Spondyloarthritis, also called Ankyloserende Spondylitis, OR
- •Pasients must have been diagnosed with non-radiografic Axial Spondyloarthritis with a positive magnetic resonance (MR).
- •Patients must have been successfully treated with NSAIDs for at least three months
- •Patients must be above 20 years old
- •Patients must satisfy the Norwegian Summary of Product Characteristics (SPC) for Ibumetin 400 mg
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients cannot participate in other clinical studies parallel to the current study. Previous study participations must be completed more than one year, prior to participating in the current study.
- •Patients not satisfying the Norwegian Summary of Product Characteristics (SPC) for Ibumetin 400 mg:
- •Patients who previously have experienced allergic reactions to NSAIDs
- •Patients with previous or currant ulcers and/or gastrointestinal conditions - or bleeding
- •Patients with previous or currant cardiovascular conditions, or have experienced cardiovascular episodes
- •Patients with previous or currant renal failure
- •Patients with acetaminophen - or NSAID-induced asthma, urticarial or rhinitt
- •Patients with previous or current other serious conditions apart from rheumatoid arthritis
- •Female patients trying to or having trouble getting pregnant cannot participate in the study
- •Pregnant and/or nursing patients cannot participate in the study
- •Patients on a treatment plan with Prednisolon
- •Patients on a treatment plan with substances inflicting with Ibumetin. All substances will be investigated on www.interaksjoner.no
研究者
相似试验
进行中（未招募）
1 期
Treating patients with early axial spondyloarthritis to target – a 1 year randomized controlled study taking an intense treatment approach versus routine treatment (STRIKE)EUCTR2015-005398-18-DEAbbVie Deutschland GmbH & Co. KG22
进行中（未招募）
1 期
Optimizing treatment strategy in axial spondyloarthritis by molecular imaging with Technetium-labeled certolizumab pegol.Axial SpondyloarthritisCTIS2023-505694-32-00niversitair Ziekenhuis Gent78
招募中
1 期
Clinical Study on the Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and Western MedicineAnkylosing SpondylitisITMCTR2100004334Guangdong Provincial Hospital of Chinese Medicine
已完成
4 期
RhEumatoid arthritis REtreatment with ultra-low dose Rituximab: Disease Outcome after Dose Optimizatiochronic inflammation of the joints1000381610023213Rheumatoid arthritisNL-OMON47117Sint Maartenskliniek140
进行中（未招募）
1 期
Strategy study in patients with peripheral spondyloarthritis, in which it is investigated whether induction of remission can be achieved more quickly with early treatment with a TNF-alpha blocker, compared to standard treatment, and in which also factors (blood, joint biopsy) that predict these outcome are investigated.EUCTR2019-004961-42-BEGhent University Hospital112